$18.34▴ 0.11%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$3.08cash per $1 profit
Strong
It turns every reported profit-dollar into real cash, and then some.
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
+7.5%year over year
Healthy
Revenue is growing at a steady pace.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
Fair value
Fairly valued
Trading right around our fair-value range
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
Simulations Plus, Inc. turns 308¢ of every reported profit-dollar into real cash. Revenue is growing at a steady pace.
Key numbers
Valuation
EPS (TTM)$0.40
TTM (trailing 12 months, through fiscal Q3 FY2026)
Profitability
Net margin9.9%
TTM (trailing 12 months, through fiscal Q3 FY2026)
Size
Revenue (TTM)$82.06M
TTM (trailing 12 months, through fiscal Q3 FY2026)
Recent news
Sentiment · last 30 days3 articles
0 bullish0 neutral3 bearish
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
Halper Sadeh LLC is Investigating Whether SLP, HUN, OLN, PULM are Obtaining Fair Deals for their Shareholders
[Latest] Global In Silico Clinical Trials Market Size/Share Worth USD 8.94 Billion by 2035 at a 15.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Signals and key numbers are from the fiscal Q3 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.